<DOC>
	<DOCNO>NCT00983320</DOCNO>
	<brief_summary>This double-blind , randomize , placebo-controlled trial measure impact quetiapine clinical experimental measure pain fibromyalgia biochemical correlate .</brief_summary>
	<brief_title>Quetiapine ( Seroquel XR ) Treatment Fibromyalgia : Clinical Mechanistic Pilot Study</brief_title>
	<detailed_description>This double-blind , randomize , placebo-controlled trial measure impact quetiapine clinical experimental measure pain fibromyalgia . The study also seek measure hormonal , immunological neurochemical correlate clinical change time .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Provision write informed consent A diagnosis Fibromyalgia use American College Rheumatology criterion Females age 18 65 year Patients unsatisfactory response previous pharmacological treatment , define score â‰¥4 pain severity item Fibromyalgia Impact Questionnaire Female patient childbearing potential must use reliable method contraception negative urine human chorionic gonadotropin ( HCG ) test enrolment Patients receive pharmacological treatment fibromyalgia Able understand comply requirement study Pregnancy lactation Patients DSMIV Axis 1 disorder MDD Chronic Pain Disorder within 6 month enrolment Elderly patient dementia behavioural disturbance Patients , investigator 's opinion , pose risk suicide Known intolerance lack response quetiapine fumarate , judge investigator Use follow cytochrome P450 3A4 inhibitor 14 day precede enrolment include limited : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine saquinavir Use follow cytochrome P450 inducers 14 day precede enrollment include limited : phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort , glucocorticoids Patients already receive antipsychotic medication Current substance abuse/dependence ( last year ) , define DSMIV criterion . Psychoactive substance include : alcohol , amphetamine , barbiturate , benzodiazepine , cannabis , cocaine , hallucinogen , opiates phencyclidine Medical condition would affect absorption , distribution , metabolism , excretion study treatment This could relate patient GI problem ( short GI transit ) , Crohn 's disease disease require treatment restrict medication indicate exclusion criterion item 5 6 . Unstable inadequately treat medical illness ( e.g . congestive heart failure , angina pectoris , hypertension , hypotension ) judge investigator , base result physical exam , ECG , haematology , chemistry urine screening Participation another drug trial within 4 week prior enrolment study A patient Diabetes Mellitus ( DM ) fulfil one follow criterion : Unstable DM define enrolment glycosylated hemoglobin ( HbA1c ) &gt; 8.5 % . Admitted hospital treatment DM DM relate illness past 12 week . Not physician care DM Physician responsible patient 's DM care indicate patient 's DM control . Physician responsible patient 's DM care approve patient 's participation study Has dose oral hypoglycaemic drug ( ) and/or diet 4 week prior randomization . For thiazolidinediones ( glitazones ) period le 8 Weeks . Taking insulin whose daily dose one occasion past 4 week 10 % mean dose precede 4 week Note : If diabetic patient meet one criterion , patient exclude even treat physician believe patient stable participate study . An absolute neutrophil count ( ANC ) less equal 1.5 x 109 per liter</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Fibromyalgia</keyword>
	<keyword>pain</keyword>
	<keyword>quetiapine</keyword>
	<keyword>randomize placebo control trial</keyword>
</DOC>